“A Most Equitable Drug”: How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug Development
Journal of Law, Medicine & Ethics · 2024
DOI: 10.1017/jme.2024.51 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Law, Medicine & Ethics, 2024. Verfasst von Quinn Grundy und 4 weiteren Autor:innen. Beteiligte Einrichtung: UNIVERSITY OF TORONTO, TORONTO, ONTARIO, CANADA. Hauptthemen laut MEDLINE: COVID-19 Serotherapy, Immunization, Passive, Public Sector, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Social Sciences and Humanities Research Council of Canada, CIHR, Mitacs.
Abstract (Originalsprache)
Interventional clinical studies of convalescent plasma to treat COVID-19 were predominantly funded and led by public sector actors, including blood services operators. We aimed to analyze the processes of clinical studies of convalescent plasma to understand alternatives to pharmaceutical industry biopharmaceutical research and development, particularly where public sector actors play a dominant role. We conducted a qualitative, critical case study of purposively sampled prominent and impactful clinical studies of convalescent plasma during 2020-2021.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UNIVERSITY OF TORONTO, TORONTO, ONTARIO, CANADA.
- DALHOUSIE UNIVERSITY, HALIFAX, NOVA SCOTIA, CANADA.
ORCID-Profile: Quinn Grundy, Matthew Herder
Förderung
- Social Sciences and Humanities Research Council of Canada
- CIHR
- Mitacs
Zitieren
APA
Grundy, Q., Campbell, C., Ali, R., Herder, M., & Holloway, K. (2024). “A Most Equitable Drug”: How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug Development. Journal of Law, Medicine & Ethics. https://doi.org/10.1017/jme.2024.51
Vancouver
Grundy Q, Campbell C, Ali R, Herder M, Holloway K. “A Most Equitable Drug”: How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug Development. Journal of Law, Medicine & Ethics. 2024. doi:10.1017/jme.2024.51
BibTeX
@article{Grundy2024,
author = {Grundy, Quinn and Campbell, Chantal and Ali, Ridwaanah and Herder, Matthew and Holloway, Kelly},
title = {“A Most Equitable Drug”: How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug Development},
journal = {Journal of Law, Medicine & Ethics},
year = {2024},
doi = {10.1017/jme.2024.51}
}
EUVIMED